eversyn

Making high-value glycans mainstream

Magdeburg, Germany · Founded 2024 · $1.9M raised

Headquarters
Magdeburg
Employees
1–10
Founded
2024
Business Model
B2B
Website
eversyn.de
Total Funding
$1.9M
Last Round
$1.9M SeedMar 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

eversyn GmbH is a spin-off of the Max Planck Institute for Dynamics of Complex Technical Systems in Magdeburg, Germany, founded and run by current and former Max Planck scientists and business professionals. The company has developed a proprietary enzymatic platform for cell-free biosynthesis of highly complex glycans at low cost and unprecedented scale, including human milk oligosaccharides (HMOs) and nucleotide sugars used in nutrition and biopharmaceuticals. eversyn's technology addresses the challenge that nucleotide sugars are 100x more expensive than gold by weight, making HMOs commercially inaccessible. The company has filed multiple patents and published peer-reviewed research. In March 2025, eversyn secured €1.6 million in seed funding to accelerate its technology platform.

Summary

eversyn is a Food & Beverage company based in Magdeburg, Germany, founded in 2024. It has raised $1.9M in total across 1 round, most recently a $1.9M Seed round in Mar 2025. Investors include bmp Ventures and Max Planck Society.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundMar 2025
$1.9M

Investors

Similar Companies

Impossible Foods

Food technology company creating plant-based meat and dairy products that replicate the taste and...

Redwood City, United States501–1000Agtech, Biotech
Series G+Total funding$1.9BNov 2021
SwiggyIPO

Swiggy is India's leading on-demand convenience platform providing food delivery, quick commerce ...

Bengaluru, India10001+Delivery, E-Commerce
Series G+Total funding$3.2BJan 2022
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Wonder

Wonder is a new kind of at-home dining experience that combines the convenience of delivery with ...

New York, United States1001–5000Food & Beverage, Food Tech
Series DTotal funding$2.8BJul 2026
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

eversyn on Indexed.vc
<a href="https://indexed.vc/companies/eversyn"><img src="https://indexed.vc/api/badge/company/eversyn" alt="eversyn on Indexed.vc" width="260" height="76" /></a>